Lymphocele formation after kidney transplantation is a frequent complication which causes pain, secondary graft loss, rehospitalizations and reoperations. Therefore, prophylaxis of lymphocele formation is of utmost importance. To assess the effectiveness of peritoneal fenestration in renal transplantation to prevent lymphocele development. A systematic literature search was conducted combined with hand-searches on lymphocele prevention following renal transplantation using peritoneal fenestration. A qualitative and quantitative analysis of included trials was conducted. We identified three trials including 414 patients and 437 transplantations which studied peritoneal fenestration. Only one randomized controlled trial was identified. Critical appraisal uncovered a number of methodological flaws, predominantly in the nonrandomized studies. Most importantly endpoint definitions varied among trials, selection bias was high and interventions and follow-up were not standardized. Metaanalysis of the included trials showed a significant reduction of clinically symptomatic lymphoceles (OR: 0.23, 95% CI: 0.09-0.64, P = 0.005) and overall postoperative fluid collections (OR: 0.49, 95% CI: 0.28-0.88, P = 0.02) without a significant increase in other surgical complications. Although peritoneal fenestration is a promising technique to reduce lymphocele formation, only few studies have investigated this technique so far. Given the low methodological quality of included trials, more studies are necessary to evaluate the effectiveness and the risks and benefits of this technique.
SUMMARY
Lymphocele formation after kidney transplantation is a frequent complication which causes pain, secondary graft loss, rehospitalizations and reoperations. Therefore, prophylaxis of lymphocele formation is of utmost importance. To assess the effectiveness of peritoneal fenestration in renal transplantation to prevent lymphocele development. A systematic literature search was conducted combined with hand-searches on lymphocele prevention following renal transplantation using peritoneal fenestration. A qualitative and quantitative analysis of included trials was conducted. We identified three trials including 414 patients and 437 transplantations which studied peritoneal fenestration. Only one randomized controlled trial was identified. Critical appraisal uncovered a number of methodological flaws, predominantly in the nonrandomized studies. Most importantly endpoint definitions varied among trials, selection bias was high and interventions and follow-up were not standardized. Metaanalysis of the included trials showed a significant reduction of clinically symptomatic lymphoceles (OR: 0.23, 95% CI: 0.09-0.64, P = 0.005) and overall postoperative fluid collections (OR: 0.49, 95% CI: 0.28-0.88, P = 0.02) without a significant increase in other surgical complications. Although peritoneal fenestration is a promising technique to reduce lymphocele formation, only few studies have investigated this technique so far. Given the low methodological quality of included trials, more studies are necessary to evaluate the effectiveness and the risks and benefits of this technique.
Introduction
Kidney transplantation (KTx) is the therapy of choice for end-stage renal disease. It provides longer survival and a better quality of life compared to nontransplanted patients [1] . In the past four decades, owing to the technical improvement in the field of surgery as well as better organ-matching systems and development of more efficient immunosuppressive regiments, KTx has become a routine operation with an acceptable mortality and morbidity rates. Morbidities include vascular and urological complications, and postoperative fluid collections, among which lymphoceles are the wellknown and challenging complication with incidence rates ranging from 0.6% to 51% [2] [3] [4] [5] [6] . Lymphoceles are usually asymptomatic and identified incidentally on routine ultrasonography. However, lymphoceles may also affect graft function by causing direct pressure to the kidney, or by compressing the ureter or transplant vasculature. In addition, ipsilateral leg or genital oedema and deep vein thrombosis after compression of the external iliac vein may occur [7, 8] .
The pathogenesis, diagnosis and therapy of lymphoceles are important points in postoperative care of KTx patients. Delay in early diagnosis and treatment can lead to graft dysfunction. The therapeutic options include interventional radiology procedures (simple aspiration, image-guided percutaneous catheter drainage with or without sclerotherapy), and surgical treatment (open or laparoscopic fenestration). Fenestration as marsupialization of the lymph collection into the peritoneal cavity by creating an internal drainage is considered the therapy of choice by many authors [4, 9, 10] . This technique is also used for management of lymphatic collections following pelvic surgery [11, 12] .
Given the frequency and consequences of post-transplantation lymphoceles, preventive measures seem highly desirable. Different preventive methods have been proposed in the literature [13] : as lymphoceles can originate from the transplanted organ as well as from unligated recipient lymphatic vessels, meticulous ligation of donor and recipient lymphatic vessels might reduce the incidence of lymphoceles [14, 15] . Furthermore, compression therapy of the lower limb after KTx has been proposed to reduce the rate of lymphoceles [16] . In addition, the immunosuppressive regime seems to influence the rate of lymphoceles and appropriate adaptation can reduce the risk [17, 18] . Some authors have used polymeric sealants/haemostatic biomaterial [7, 19] or povidone-iodine [20] to reduce lymphocele formation; however, these methods either lack high-quality evidence, are not cost-effective or did not significantly decrease post-KTx lymphoceles. The use of drains to prevent lymphocele formation is controversial [18, 21] . Finally, peritoneal fenestration at the time of KTx has been proposed as a simple surgical method to prevent lymphocele formation. Peritoneal fenestration is widely used to treat lymphoceles following KTx [4, 9, 10] ; however, is used as prophylactic measure; and is less well described. The aim of this study was therefore to evaluate the benefits and harms of prophylactic fenestration of the peritoneal cavity in KTx based on the current literature.
Materials and methods
This systematic review is reported in line with current PRISMA guidelines [28] .
Protocol and registration
The systematic review and meta-analysis was conducted according to a prespecified protocol, which is available upon request.
Eligibility criteria
The patient-intervention-comparison-outcome (PICO) scheme was used to build the search strategy using search terms describing patients (KTx) and the intervention (peritoneal fenestration). The search strategy for the MEDLINE search via Ovid SP is shown in Table 1 . The search strategies for the other databases were adapted to the specific vocabulary of each database. No language or time restrictions were applied. Moreover, the references of the included articles were hand-searched to identify additional relevant studies. All RCT, controlled clinical trials (CCT), case series and retrospective analyses of databases were included. Case reports were excluded from analyses. Reviews, editorials, letters and comments were used to identify primary data.
Information sources
A systematic literature search of the electronic databases Medline R and Medline R In-process and other 
Summary measures and synthesis of results
Principal summary measures were mean and standard deviation (SD) for continuous parameters where the mean difference was measured. For dichotomous outcomes the number of events and total numbers were extracted and the odds ratio (OR) was measured.
Results are presented with 95% confidence interval (CI). For each outcome, statistical analysis and pairwise meta-analysis have been performed using the MantelHaenszel random effects method (Review Manager, Version 5.3 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). Between trials and within each study, heterogeneity was evaluated using I² and results of over 60% were considered as substantial heterogeneity.
Results

Study selection
A total of 270 studies were identified after the initial search of databases. Additionally, two articles were identified by hand search. Of these 272 articles, 49 duplicates and 211 nonrelevant studies were excluded after reading the title and abstract (PRISMA flow chart, see Fig. 1 ). Most articles excluded at this point described either different interventions (no peritoneal fenestration) or described the treatment, not prophylaxis, of lymphoceles. Consequently, twelve full-text articles were assessed for eligibility. After further assessment of these studies, nine studies were excluded because they either described the wrong intervention [18, [21] [22] [23] [24] [25] [26] , contained no primary data (review) [5] , described treatment, but not prophylaxis of lymphoceles [27] or were abstracts corresponding to a study [8] . Therefore, three trials met the inclusion criteria and were used for data extraction, and further qualitative and quantitative analysis [8, 29, 30 ] (see Table 2 ).
Study characteristics
In total, one RCT [8] and two case series were identified [29,30] ( Table 2 ). All trials were monocentric. The trials included a total of 414 patients and 437 transplants. Data were reported on 194 transplants with fenestration and 243 control transplants (no fenestration). Only the RCT by Syversveen et al. [8] clearly described baseline patient characteristics showing no significant difference between patient groups. The study by Zaontz et al.
[29] was performed in paediatric patients, but no further patient details were reported. Similarly, the study by Layman et al.
[30] did not specify patient characteristics. Furthermore, with the exception of the RCT by Syversveen et al. [8] , all other studies did not specify the immunosuppressive regime nor gave precise data on the follow-up.
Risk of bias within and across studies
Both case series [29, 30] exhibited considerable risk of bias as illustrated in the Downs and Black table (Table 3) . However, even in the RCT by Syversveen et al. bias could not be excluded in all categories (see Cochrane risk of bias table, Table 3 ). Both of the two case series did not report details on immunosuppressive therapy. Furthermore, lymphocele definitions varied between studies. All of them distinguished between radiologic fluid collections and symptomatic, clinically relevant lymphoceles. Syversveen et al. [8] used any symptomatic lymphoceles (defined as lymphoceles requiring surgical or radiological intervention) after 1 year as their primary outcome, but also reported the rate of hypoechoic peri-renal collection on ultrasound after 1, 5 and 10 weeks post surgery as secondary endpoints. Layman et al.
[30] reported any fluid collection more than 2 cm, that "did not appear to be a haematoma," but distinguished those from symptomatic lymphoceles defined as any of the above fluid collections with need for intervention. Zaontz et al. [29] reported only lymphoceles that needed treatment. Given that only three studies have been published so far, evaluation of the risk of bias across studies via funnel plot is meaningless.
Symptomatic lymphoceles
Meta-analysis of all included studies regarding the risk of symptomatic lymphocele (Fig. 2a) showed a significant reduction in lymphocele formation in the fenestration group compared to that in controls (OR: 0.19, 95% CI: 0.07-0.52, P = 0.001, I² = 0%).
Fluid collections
When radiologic fluid collections where compared, irrespectable of clinical significance, rates were much higher. Again, significantly less fluid collections were detected in the fenestration group compared to controls (OR: 0.49, 95% CI: 0.28-0.88, P = 0.02, I² = 56%). However, heterogeneity is high. Zanontz et al. [29] did not report the rate of sonographic fluid collections as this was not part of standard diagnostic follow-up at the time the study was performed.
Treatment of lymphoceles
In the study by Layman et al., of the seven symptomatic lymphoceles, three were treated with percutaneous drainage and three with open window (all in the non-fenestration group). The intervention in the remaining patient (fenestration group) remained unclear [30] .
In the study by Zaontz et al.
[29], a total of 11 lymphoceles were reported: external marsupializations and drainage were used in five cases; intraperitoneal fenestration and internal drainage in five cases; and repeated aspiration, marsupializations and drainage in one case as therapeutic approach. Lymphoceles resolved within a maximum of 4 months after treatment.
In the RCT by Syversveen et al., the 11 symptomatic lymphoceles that developed in the per protocol analysis, population were treated with laparoscopic fenestration in two cases, open surgery in four cases (including 2 RCT, randomized-controlled trial; CCT, controlled clinical trial; CS, case series. Is the hypothesis/aim/objective of the study clearly described Yes "To avoid the development of a lymphocele we have used a technique of intraperitoneal fenestration at the time of transplantation, based on the concept that nonligated allograft and/or iliac lymphatics will drain intraperitoneal and not accumulate within the pelvis." 2. Are the main outcomes to be measured clearly described in the Introduction or Methods section Yes "All patients were monitored after transplantation with renal scans, physical and laboratory examinations, and with ultrasonography if a fluid collection was suspected by unexplained changes in renal function" 3. Are the characteristics of the patients included in the study clearly described No Only paediatric patients, but no further details are reported laparoscopic conversions) and percutaneous drainage in five cases. The authors reported that treatment of lymphoceles led to 10 readmissions and 43 days of hospitalization.
Overall complications
Only the study by Syversveen et al. [8] reported overall complications in their patient cohort. Although reoperations for lymphoceles were significantly reduced in the fenestration group compared with those in controls, the total number of reoperations was not (14 vs. 17 reoperations; RR: 0.72; P = 0.30) as fenestration patients had more ureter strictures/leaks (7 vs. 3, RR: 2.1; P = 0.033) and more intestinal obstructions (3 vs. 1, RR: 0.88; P = 0.62). Three patients in the standard group and one patient in the intervention group died within 1 year. Furthermore, there were two graft losses in the standard group and one in the fenestration group.
Discussion
Lymphocele formation is a frequent complication following KTx when extraperitoneal placement of the graft in the iliac fossa is performed. Several preventive measures have been proposed to reduce lymphocele formation (reviewed in Ref. [13] ) including meticulous ligation of lymphatic vessels at the time of surgery in both donor and recipient [15] , compression therapy of the lower extremities [16] , haemostatic/polymeric sealants [7, 19] , drains [18, 21] and certain immunosuppressive regimes [17, 18] . Peritoneal fenestration has been proposed as a simple surgical method to reduce postKTx lymphocele formation. Although peritoneal fenestration has been described more than four decades ago as a surgical technique to avoid lymphocele formation and is accepted standard for lymphocele drainage in many transplantation centres across the world, astonishingly few studies have evaluate this technique as prophylactic measure. We were able to identify only two case series and one RCT evaluating peritoneal for lymphocele prevention [8, 29] . All studies, but the RCT, were at high risk of bias as they were single-centre investigations with unclear follow-up, immunosuppression regimes, selection bias, historic control groups and allocation bias. Therefore, results have to be treated with caution. Furthermore, no risk-benefit judgement is possible from these studies as only lymphocele rates, but no fenestration-associated complications, are reported. Only the trial by Syversveen et al. [8] is designed as a prospective randomized study and exhibits the lowest risk of bias of all included studies. However, even in this trial, bias cannot be excluded as not all consecutive patients were enrolled and the trial was performed at a single centre. The latter also limits external validity of the results. Interestingly, overall reoperation rates did not differ between the two groups mostly because of more ureter-associated complications in the fenestration group. The reason for this remains unclear.
In addition, patients in the fenestration group showed a (nonsignificant) trend towards more intestinal complications (3 in the fenestration group vs. 1 in the control group, RR:0.88; P = 0.62) [28] . This might be because of an increased risk of intestinal obstruction if bowel becomes incarcerated in the peritoneal window. However, given the limited data, a full risk-benefit assessment of peritoneal fenestration is currently not possible.
Additionally, there are other factors influencing the occurrence of lymphocele after KTx. On the one hand, the initial steroid dose and the time for withdrawal of steroids after KTx significantly affect the incidence of postoperative lymphoceles. Lower steroid doses and early withdrawal of steroids after KTx are considered to reduce lymphocele rates [2, 17] . On the other hand, earlier studies have described intraoperative placing of prophylactic drainages to reduce the risk of lymphoceles after KTx [18] . Both these factors have not been reported properly in the studies included in this systematic review, and there have been no standardized therapy regimes regarding the placement of intraoperative drainages or initial postoperative steroid therapy. Therefore, validity of the results is limited.
Given the promising results of this systematic review and considering the limitations of this study, especially the limited external validity and high-risk of bias of some of the included trials, peritoneal fenestration warrants further evaluation in high-quality prospective trials. These trials should standardize intervention as well as follow-up and control for all known confounders of post-KTx lymphocele development. Furthermore, trials should report on all complications, including peritoneal fenestration-associated complications to allow for an unbiased risk-benefit assessment.
Conclusion
This systematic review accumulates current evidence of prophylactic peritoneal fenestration after KTx and its effect on lymphocele formation. Although results are promising, more data on peritoneal fenestration are urgently needed to evaluate its efficacy and effectiveness. These data should be obtained in an RCT design with a modern immunosuppressive therapy regime and, especially, other factors influencing the development of lymphoceles, like steroid therapy and intraoperative drainages, should be standardized between patients. Importantly, future trials should have clear follow-up and end point definitions, and report all complications to allow for a clear risk-benefit assessment.
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